{
    "clinical_study": {
        "@rank": "25081", 
        "arm_group": [
            {
                "arm_group_label": "geko\u2122", 
                "arm_group_type": "Experimental", 
                "description": "geko\u2122 use continually post-surgery for 48hrs and then a minimum of 4hrs/day until discharge"
            }, 
            {
                "arm_group_label": "TEDS stockings", 
                "arm_group_type": "Active Comparator", 
                "description": "TEDS use continually post-surgery for 48hrs and then a minimum of 4hrs/day until discharge"
            }
        ], 
        "brief_summary": {
            "textblock": "This study hypothesises that the geko\u2122 device is more efficient than TEDS in preventing the\n      formation of symptomatic/asymptomatic Deep Vein Thrombosis (DVTs), post-surgery."
        }, 
        "brief_title": "Geko Neuromuscular Stimulator vs Thromboembolism Deterrent Stockings (TEDS): DVT Prevention Study", 
        "condition": "Deep Vein Thrombosis", 
        "condition_browse": {
            "mesh_term": [
                "Thromboembolism", 
                "Thrombosis", 
                "Venous Thrombosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Aged 18 years of age and over\n\n          2. Free of significant abnormal findings as determined by medical history (specifically\n             an absence of DVT or haematological disorders).\n\n          3. Has not used any medications (prescribed or over-the-counter including herbal\n             remedies) judged to be significant by the Principal Investigator during the ten (10)\n             days preceding enrolment.\n\n          4. Able to understand the Patient Information Sheet and willing to sign the written\n             Informed Consent Form.\n\n          5. Able and willing to follow the protocol requirements.\n\n        Exclusion Criteria:\n\n          1. Are requiring hip revision surgery\n\n          2. History or signs of previous deep or superficial vein thrombosis/pulmonary embolism.\n\n          3. Evidence of asymptomatic DVT by Duplex Ultrasound\n\n          4. Peripheral arterial disease (ABPI < 0.8), varicose veins or lower limb ulceration or\n             ischemia.\n\n          5. Significant varicose veins, phlebitis or lower limb ulceration or ischemia. CEAP\n             Grade 4-6. See Appendix  2\n\n          6. Recent surgery within the last 3 months (such as abdominal, gynaecological, hip or\n             knee replacement).\n\n          7. Recent trauma to lower limb.\n\n          8. Chronic Obesity (BMI Index >40kg/m2).\n\n          9. Pregnancy.\n\n         10. Significant history of following diseases I. Cardiovascular: Recent MI (< 6 months)\n             II. Percutaneous Coronary Intervention (PCI) with stent (< 3 months for Bare Metal\n             Stent (BMS) and < 12 months for Drug Eluding Stent (DES) III. Moderate to severe CCF,\n             uncontrolled AF IV. Neurological: Stroke, Hemiplegia/Paraplegia, Myopathies V.\n             Significant dermatological conditions affecting lower limbs resulting in broken or\n             inflamed skin particularly at the site where the device is to be fitted.\n\n             VI. Clinically significant haematological conditions i.e. coagulation disorders,\n             sickle cell disease VII. Psychiatric disorders\n\n         11. On LMWH/Heparin (Prophylactic/therapeutic doses) or Warfarin or warfarin stopped\n             recently and replaced by LMWH/ Heparin\n\n         12. Long term steroid with dermatological changes\n\n         13. A pulse rate of less than 40 beats/minute\n\n         14. A sitting systolic blood pressure >180 and <100 mmHg and/or a sitting diastolic\n             pressure of >100 mmHg.\n\n         15. Any significant illness during the four (4) weeks preceding the hip replacement\n             surgery.\n\n         16. Participation in any clinical study during the eight (8) weeks preceding the\n             screening period"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01935414", 
            "org_study_id": "FKD-TEDS-001"
        }, 
        "intervention": [
            {
                "arm_group_label": "geko\u2122", 
                "intervention_name": "geko\u2122 post-surgery for 48hrs then 4hrs/day until discharge.", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "TEDS stockings", 
                "intervention_name": "TEDS post-surgery for 48hrs then 4hrs/day until discharge.", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 30, 2013", 
        "link": {
            "description": "Company website", 
            "url": "http://www.gekodevices.com/en-uk/"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Poole", 
                    "country": "United Kingdom", 
                    "state": "Dorset", 
                    "zip": "BH15 2BH"
                }, 
                "name": "BMI The Harbour Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multicentre Randomised Controlled Trial Comparing the Incidence of Asymptomatic and Symptomatic Deep Vein Thrombosis Between the gekoTM Device and Thromboembolism Deterrent Stockings in Patients Recovering From Total Hip Replacement Surgery", 
        "overall_contact": {
            "email": "matthew.womack@firstkindmedical.com", 
            "last_name": "Matthew Womack, PhD", 
            "phone": "+44(0) 7456427910"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Presence of asymptomatic DVT assessed by Duplex Ultrasound", 
            "safety_issue": "Yes", 
            "time_frame": "6 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01935414"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Firstkind Ltd", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Firstkind Ltd", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}